Framework developmentThe governance framework was developed through background research on international guidance and best practices, patient surveys, analysis of internal data and software systems, integration with Māori data sovereignty principles21, and establishment of a representative…
Source: www.nature.com – Read more
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
